arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

NEPHROS INC

NEPH
$3.11 ▼ -0.09 (-2.81%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
66 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
74
Health
Good
Neutral
auto_awesome

Analytical Summary

NEPHROS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $33.8M
Dividend Yield —
Revenue Growth 36.2% ↗
Op. Margin 20.2% ↗
ROIC None
FCF / Share $0.06 ↗
Trailing P/E 28.3x
Price / Book —
FCF Yield 2.0%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$6.02M
↑ +36.2% —
Net Income Profit after all expenses
$140.00K
↓ -74.9% —
Operating Margin Operating profit as % of sales
20.2%
↑ +983.2% 46th
FCF / Share Free cash flow per share
$0.06
↑ +140.0% —
Long-Term Debt Long-term obligations
$141.00K
↓ -32.9% —

Health Breakdown

Profitability
52
Financial Health
99
Cash Quality ↑
78

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 66 quarters